eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all . Please read our guidelines before submitting your own eLetter.
Research ArticleIMMUNOLOGY
TRAF6-IRF5 kinetics, TRIF, and biophysical factors drive synergistic innate responses to particle-mediated MPLA-CpG co-presentation
- View ORCID ProfileP. Pradhan1,2,3,*,
- View ORCID ProfileR. Toy1,*,
- View ORCID ProfileN. Jhita4,
- View ORCID ProfileA. Atalis1,
- View ORCID ProfileB. Pandey1,
- A. Beach1,
- E. L. Blanchard1,
- View ORCID ProfileS. G. Moore2,
- View ORCID ProfileD. A. Gaul2,
- View ORCID ProfileP. J. Santangelo1,
- View ORCID ProfileD. M. Shayakhmetov4,5 and
- View ORCID ProfileK. Roy1,2,3,†
- 1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
- 2The Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA.
- 3Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, Atlanta, GA, USA.
- 4Lowance Center of Human Immunology, Department of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA.
- 5Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
- ↵†Corresponding author. Email: krish.roy{at}gatech.edu
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Advances 13 Jan 2021:
Vol. 7, no. 3, eabd4235
DOI: 10.1126/sciadv.abd4235
Vol. 7, no. 3, eabd4235
DOI: 10.1126/sciadv.abd4235
P. Pradhan
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
2The Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA.
3Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, Atlanta, GA, USA.
R. Toy
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
N. Jhita
4Lowance Center of Human Immunology, Department of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA.
A. Atalis
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
B. Pandey
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
A. Beach
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
E. L. Blanchard
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
S. G. Moore
2The Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA.
D. A. Gaul
2The Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA.
P. J. Santangelo
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
D. M. Shayakhmetov
4Lowance Center of Human Immunology, Department of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA, USA.
5Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
K. Roy
1The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
2The Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA.
3Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, Atlanta, GA, USA.
Submit a Response to This Article
No eLetters have been published for this article.